newsfilter
← Latest News
Business Wire·

Zura Bio to Present at the Jefferies Global Healthcare Conference

Zura Bio Limited (NASDAQ:ZURA) ("Zura Bio" or the "Company"), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for a range of autoimmune and inflammatory diseases, today